series-a
Stage
About
Bionyra Pharma is a clinical-stage biopharmaceutical company based in Paris developing next-generation monoclonal and multispecific antibody therapeutics, including half-life extension engineering, to treat severe immune-mediated inflammatory diseases. Its pipeline comprises clinical- and IND-stage biologics for inflammatory and immune-mediated conditions.
Explore Bionyra Pharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.